ICG Strategic Secondaries Advisors LLC
Overview
ICG Strategic Equity (ICGSE) is a specialist private equity investor focused exclusively on the GP-led secondaries market. Since its launch in 2014, ICGSE has committed over $19 billion into some of the largest and most complex continuation vehicle secondary transactions globally. ICGSE backs blue-chip financial sponsors to enable continued value creation in private equity assets, in transactions that also provide a liquidity option for existing investors. ICG provides flexible capital solutions to help companies develop and grow. We are a global alternative asset manager with over 30 years' history, operating across four asset classes: Structured and Private Equity, Private Debt, Real Assets, and Credit.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Datasite | May 2024 | Secondary | Lead |
| Visma | Dec 2023 | Private Equity | - |
| United Petfood | Apr 2021 | Secondary | - |
| Curium Pharma | Dec 2020 | Private Equity | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.